Using three CRC-derived lines as a cellular model, we have identified a signaling pathway that integrates insulin and leptin signaling in the activation of MEK1/2 and leads to up-regulation of miR-4443, which in turn down-regulates NCOA1 and TRAF4, possibly causing tumor suppression and decreased cell invasion. The gene discussed is LEP; the disease is neoplasm.